MDT

88.44

-1.53%↓

VEEV

227.74

-1.64%↓

A

113.65

-2.76%↓

HQY

87.08

-1.46%↓

PDCO

31.26

0%↓

MDT

88.44

-1.53%↓

VEEV

227.74

-1.64%↓

A

113.65

-2.76%↓

HQY

87.08

-1.46%↓

PDCO

31.26

0%↓

MDT

88.44

-1.53%↓

VEEV

227.74

-1.64%↓

A

113.65

-2.76%↓

HQY

87.08

-1.46%↓

PDCO

31.26

0%↓

MDT

88.44

-1.53%↓

VEEV

227.74

-1.64%↓

A

113.65

-2.76%↓

HQY

87.08

-1.46%↓

PDCO

31.26

0%↓

MDT

88.44

-1.53%↓

VEEV

227.74

-1.64%↓

A

113.65

-2.76%↓

HQY

87.08

-1.46%↓

PDCO

31.26

0%↓

Search

Smith & Nephew PLC ADR

Открыт

28.18 -0.46

Обзор

Изменение цены акций

24 ч

Текущая

Мин.

27.91

Макс.

28.53

Ключевые показатели

By Trading Economics

Доход

-16M

198M

Продажи

156M

3B

P/E

Средняя по отрасли

29.819

73.239

Дивидендная доходность

2.68

Рентабельность продаж

6.638

Сотрудники

17,349

EBITDA

197M

717M

Рекомендации

By TipRanks

Рекомендации

Покупка

Прогноз на 12 месяцев

+1.5% upside

Дивиденды

By Dow Jones

Дивидендная доходность

Средняя по отрасли

2.68%

3.06%

Рыночная статистика

By TradingEconomics

Рыночная капитализация

-650M

12B

Предыдущая цена открытия

28.64

Предыдущая цена закрытия

28.18

Техническая оценка

By Trading Central

Уверенность

Strong Bearish Evidence

Smith & Nephew PLC ADR График

Прошлые результаты не являются надежным индикатором будущих результатов.

Связанные новости

31 мар. 2025 г., 22:45 UTC

Главные новости

Intel's New CEO Plots Turnaround; 'We Need to Improve'

31 мар. 2025 г., 23:54 UTC

Обсуждения рынка

Nikkei May Rise After Monday's Selloff -- Market Talk

31 мар. 2025 г., 23:44 UTC

Обсуждения рынка

Gold Edges Higher Amid Prospects of Broader, Higher U.S. Tariffs -- Market Talk

31 мар. 2025 г., 23:15 UTC

Обсуждения рынка

Tower Shares Ease After Bain Capital Exit -- Market Talk

31 мар. 2025 г., 23:15 UTC

Обсуждения рынка

Global Equities Roundup: Market Talk

31 мар. 2025 г., 22:33 UTC

Главные новости

Trump Administration Targets Harvard With Review of $9 Billion in Federal Funding -- Update

31 мар. 2025 г., 22:28 UTC

Отчет

China Vanke: Weak China Real-Estate Market Weighed on Results >000002.SZ

31 мар. 2025 г., 22:28 UTC

Отчет

China Vanke 2024 Loss CNY49.48B Vs. Net CNY12.16B >000002.SZ

31 мар. 2025 г., 22:28 UTC

Отчет

China Vanke 2024 Rev CNY343.18B Vs. CNY465.74B >000002.SZ

31 мар. 2025 г., 22:28 UTC

Отчет

China Vanke Swings to Loss for 2024 >000002.SZ

31 мар. 2025 г., 21:47 UTC

Главные новости

Intel's New CEO Says Turnaround 'Won't Be Easy' -- Barrons.com

31 мар. 2025 г., 21:44 UTC

Главные новости

Trump Administration Targets Harvard With Review of $9 Billion in Federal Funding -- WSJ

31 мар. 2025 г., 21:21 UTC

Обсуждения рынка

Intel Has 'A Lot of Hard Work Ahead' in Turnaround, CEO Says -- Market Talk

31 мар. 2025 г., 21:18 UTC

Главные новости

Copper Is 2025's Hottest Commodity -- Update

31 мар. 2025 г., 21:09 UTC

Главные новости

Senate Aims to Advance Trump Tax Agenda While Postponing Spending-Cut Fight -- Update

31 мар. 2025 г., 21:02 UTC

Отчет

Freeport-McMoRan Sees 1Q Gold Sales 100,000 Ounces Below Previous Guidance of 225,000 Ounces >FCX

31 мар. 2025 г., 21:01 UTC

Отчет

Freeport-McMoRan Backs 1Q Consolidated Copper Sales of 850M Pounds >FCX

31 мар. 2025 г., 20:50 UTC

Обсуждения рынка

Financial Services Roundup: Market Talk

31 мар. 2025 г., 20:50 UTC

Обсуждения рынка

Basic Materials Roundup: Market Talk

31 мар. 2025 г., 20:37 UTC

Главные новости

A Wild Quarter for U.S. Stocks Sends Investors Abroad -- 3rd Update

31 мар. 2025 г., 20:17 UTC

Главные новости

Dow Bounced Back After Tariff Concerns Hit Global Markets -- WSJ

31 мар. 2025 г., 20:13 UTC

Главные новости

A Wild Quarter for U.S. Stocks Sends Investors Abroad -- 2nd Update

31 мар. 2025 г., 20:03 UTC

Главные новости

A Wild Quarter for U.S. Stocks Sends Investors Abroad -- Update

31 мар. 2025 г., 19:09 UTC

Обсуждения рынка

Oil At 5-Week High as Trump Makes More Sanction Threats -- Market Talk

31 мар. 2025 г., 18:56 UTC

Обсуждения рынка

U.S. Natural Gas Gains With Help From Weather -- Market Talk

31 мар. 2025 г., 18:54 UTC

Обсуждения рынка

Canadian Banks' Fundamentals to Support Credit Ratings Near Term -- Market Talk

31 мар. 2025 г., 18:40 UTC

Обсуждения рынка

Walmart's Low Income Consumer Appears Increasingly Strained -- Market Talk

31 мар. 2025 г., 18:34 UTC

Обсуждения рынка

Ball, Crown Won't Be Materially Hurt if Soda Kicked Off Food Stamps -- Market Talk

31 мар. 2025 г., 18:28 UTC

Обсуждения рынка

Gold Climbs to Close Out Quarter -- Market Talk

31 мар. 2025 г., 18:03 UTC

Главные новости

Dow Edges Higher, Tariff Concerns Drag Down Global Markets -- WSJ

Сравнение c конкурентами

Изменение цены

Smith & Nephew PLC ADR Прогноз

Целевая цена

By TipRanks

1.5% рост

Прогноз на 12 месяцев

Средняя 28.47 USD  1.5%

Максимум 30.7 USD

Минимум 27 USD

Основано на мнении 3 аналитиков Wall Street, спрогнозировавших целевые цены для Smith & Nephew PLC ADR на следующие 12 месяцев – Данные за последние 3 месяца.

Консенсус по рейтингу

By TipRanks

Покупка

3 ratings

1

Покупка

2

Удержание

0

Продажа

Техническая оценка

By Trading Central

28.23 / 28.39Поддержка и Сопротивление

Краткосрочная

Strong Bearish Evidence

Среднесрочная

Weak Bullish Evidence

Долгосрочная

Bullish Evidence

Финансовые показатели

Расходы на продажи и администрирование

Операционные расходы

Прибыль до уплаты налогов

Продажи

Себестоимость реализации

Валовая прибыль от продаж

Процентные расходы по долгу

EBITDA

Операционная прибыль

$

О компании Smith & Nephew PLC ADR

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products. It also provides sports medicine joint repair products comprise instruments, technologies, and implants to perform minimally invasive surgery, as well as treating soft tissue injuries and degenerative conditions of the shoulder, knee, hip, and small joints. In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, high-definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg wounds, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, such as biologics and other bioactive technologies for debridement and dermal repair/regeneration, and regenerative medicine products, including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. The company serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.